Publications by authors named "Clare Slaney"

Claim this Profile
T
Targeting PTPN2 enhances human CAR T cell efficacy and the development of long-term memory in mouse xenograft models.
Xin Du, Pei K Goh, Chenkai Ma, Eamon Coughlan, Spencer Greatorex, Clare Y Slaney

Sci Transl Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimised modular anti-FLAG CAR T cells for solid tumor therapy.
Xiaomeng Zhang, Rachel Xu, Dmitry Zorin, Evan G Pappas, Jiawei Tang, Clare Y Slaney

Clin Transl Immunology· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Choice of activation protocol impacts the yield and quality of CAR T cell product, particularly with older individuals.
Palak H Mehta, Gemma S Trollope, Patrick Leung, Shivali Savita Chinni, Anna Iasinskaia, Clare Y Slaney

Clin Transl Immunology· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy.
Jack D Chan, Christina M Scheffler, Isabelle Munoz, Kevin Sek, Joel N Lee, Clare Y Slaney

Nature· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models.
Deborah Meyran, Joe Jiang Zhu, Jeanne Butler, Daniela Tantalo, Sean MacDonald, Clare Slaney

Sci Transl Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
YBX1 integration of oncogenic PI3K/mTOR signalling regulates the fitness of malignant epithelial cells.
Yuchen Bai, Carolin Gotz, Ginevra Chincarini, Zixuan Zhao, Clare Slaney

Nat Commun· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights into Cancer Immunotherapies: Recent Breakthroughs, Opportunities, and Challenges.
Evan G Pappas, Michael H Kershaw, Clare Y Slaney

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Combining chemo/radio therapy and immunotherapy for cancers-perfect mix of old and new.
Clare Y Slaney, Peng Luo, Feng-Ming Kong, Linlang Guo, Jian Zhang

Front Immunol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular networks controlling T cell persistence in adoptive cell therapy.
Jack D Chan, Junyun Lai, Clare Y Slaney, Axel Kallies, Paul A Beavis

Nat Rev Immunol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing Adoptive Cell Transfer with Combination BRAF-MEK and CDK4/6 Inhibitors in Melanoma.
Peter Kar Han Lau, Carleen Cullinane, Susan Jackson, Rachael Walker, Lorey K Smith, Clare Y Slaney

Cancers (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Histone Deacetylase Inhibitor, Panobinostat, Enhances Chimeric Antigen Receptor T-cell Antitumor Effect Against Pancreatic Cancer.
Aesha I Ali, Minyu Wang, Bianca von Scheidt, Pilar M Dominguez, Aaron J Harrison, Clare Y Slaney

Clin Cancer Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding T cell phenotype for the design of effective chimeric antigen receptor T cell therapies.
Daniela Gm Tantalo, Amanda J Oliver, Bianca von Scheidt, Aaron J Harrison, Scott N Mueller, Clare Y Slaney

J Immunother Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-talk between tumors at anatomically distinct sites.
Amanda J Oliver, Phillip K Darcy, Joseph A Trapani, Michael H Kershaw, Clare Y Slaney

FEBS J· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing co-stimulation of CAR T cells to improve treatment outcomes in solid cancers.
Aaron J Harrison, Xin Du, Bianca von Scheidt, Michael H Kershaw, Clare Y Slaney

Immunother Adv· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges and Opportunities for Effective Cancer Immunotherapies.
Clare Y Slaney, Michael H Kershaw

Cancers (Basel)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel combination immunotherapy for pancreatic cancer: potent anti-tumor effects with CD40 agonist and interleukin-15 treatment.
Jonas Rm Van Audenaerde, Elly Marcq, Bianca von Scheidt, Ashleigh S Davey, Amanda J Oliver, Clare Y Slaney

Clin Transl Immunology· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary and metastatic breast tumors cross-talk to influence immunotherapy responses.
Amanda J Oliver, Simon P Keam, Bianca von Scheidt, Damien J Zanker, Aaron J Harrison, Clare Y Slaney

Oncoimmunology· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current status, challenges and perspectives: immunotherapy and tumour microenvironment in thoracic cancer.
Peng Luo, Clare Y Slaney, Jian Zhang

J Thorac Dis· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue-specific tumour microenvironments are an emerging determinant of immunotherapy responses.
Amanda J Oliver, Phillip K Darcy, Michael H Kershaw, Clare Y Slaney

J Thorac Dis· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric antigen receptor T cell therapies for thoracic cancers-challenges and opportunities.
Jack D Chan, Aaron J Harrison, Phillip K Darcy, Michael H Kershaw, Clare Y Slaney

J Thorac Dis· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing chimeric antigen receptor T-cell immunotherapy against cancer using a nanoemulsion-based vaccine targeting cross-presenting dendritic cells.
Jack D Chan, Bianca von Scheidt, Bijun Zeng, Amanda J Oliver, Ashleigh S Davey, Clare Y Slaney

Clin Transl Immunology· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enterotoxins can support CAR T cells against solid tumors.
Bianca von Scheidt, Minyu Wang, Amanda J Oliver, Jack D Chan, Metta K Jana, Clare Y Slaney

Proc Natl Acad Sci U S A· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue-specific tumor microenvironments influence responses to immunotherapies.
Amanda J Oliver, Ashleigh S Davey, Simon P Keam, Sherly Mardiana, Jack D Chan, Clare Y Slaney

Clin Transl Immunology· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Redirection of T Cells for the Treatment of Pancreatic Cancer.
Aesha I Ali, Amanda J Oliver, Tinaz Samiei, Jack D Chan, Michael H Kershaw, Clare Y Slaney

Front Oncol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4Foxp3 Cell-Mediated Modulation of CD103 Dendritic Cells.
Paul A Beavis, Melissa A Henderson, Lauren Giuffrida, Alexander J Davenport, Emma V Petley, Clare Y Slaney

Cancer Immunol Res· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis